| pH-sensitive Eudragit nanoparticles for mucosal drug delivery JW Yoo, N Giri, CH Lee International journal of Pharmaceutics 403 (1-2), 262-267, 2011 | 177 | 2011 |
| Nanotechnology-based approaches for targeting and delivery of drugs and genes V Mishra, P Kesharwani, MCIM Amin, A Iyer Academic Press, 2017 | 111 | 2017 |
| Biodegradable polymeric nanostructures in therapeutic applications: opportunities and challenges SK Shukla, SK Shukla, PP Govender, NG Giri RSC advances 6 (97), 94325-94351, 2016 | 55 | 2016 |
| Dendrimers based cancer nanotheranostics: An overview V Saluja, Y Mishra, V Mishra, N Giri, P Nayak International Journal of Pharmaceutics 600, 120485, 2021 | 39 | 2021 |
| Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B N Giri, P Tomar, VS Karwasara, RS Pandey, VK Dixit Acta Biochim Biophys Sin 43 (11), 877-883, 2011 | 34 | 2011 |
| Dendrimers in targeting and delivery of drugs P Kesharwani, MCIM Amin, N Giri, A Jain, V Gajbhiye Nanotechnology-based approaches for targeting and delivery of drugs and …, 2017 | 28 | 2017 |
| Quinoline‐derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review V Yadav, J Reang, V Sharma, J Majeed, PC Sharma, K Sharma, N Giri, ... Chemical Biology & Drug Design 100 (3), 389-418, 2022 | 26 | 2022 |
| Dendrimer based nanoarchitectures in diabetes management: An overview V Mishra, N Yadav, GK Saraogi, MM Tambuwala, N Giri Current Pharmaceutical Design 25 (23), 2569-2583, 2019 | 26 | 2019 |
| Stimuli-sensitive nanoparticles for multiple anti-HIV microbicides N Giri, B Oh, CH Lee Journal of Nanoparticle Research 18, 1-16, 2016 | 9 | 2016 |
| Identification of novel selective Mtb‐DHFR inhibitors as antitubercular agents through structure‐based computational techniques K Sharma, N Neshat, S Sharma, N Giri, A Srivastava, F Almalki, ... Archiv der Pharmazie 353 (2), 1900287, 2020 | 7 | 2020 |
| Prevention of structural perturbation and aggregation of hepatitis B surface antigen: screening of various additives P Tomar, N Giri, VS Karwasara, RS Pandey, VK Dixit Pharmaceutical Development and Technology 17 (4), 421-428, 2012 | 6 | 2012 |
| Bilayer tablet based Chronotherapeutics in the Management of Nocturnal Asthma: An Overview LKG Sourav Thakur, Bhupendra Singh, Vijay Mishra*, Nishika Yadav, Namita ... Recent Patents on Drug Delivery & Formulation, (E-pub Abstract Ahead of Print), 2019 | 5* | 2019 |
| Interprofessional perceptions and attitudes among pharmacy and family nurse practitioner students CM Vinluan, A Verdell, C Ibarra, N Giri, D Thai Journal of Pharmacy Practice 33 (6), 815-819, 2020 | 4 | 2020 |
| A cascade computer model for mocrobicide diffusivity from mucoadhesive formulations Y Lee, A Khemka, G Acharya, N Giri, CH Lee BMC bioinformatics 16, 1-12, 2015 | 4 | 2015 |
| Advanced Mucus Infiltrating Nanoparticles for Microbicide Delivery NGiri, CH Lee Journal of J Nanomedicine & Nanotechnology 9 (DOI: 10.4172/2157-7439.1000479 …, 2017 | 1 | 2017 |
| Design of stimuli-sensitive microbicide formulations CH Lee, N Giri Drug delivery and development of anti HIV microbicides, 377-414, 2014 | 1 | 2014 |
| Nanotechnology in Agricultural Practices: Prospects and Potential NG Giri, NS Abbas, SK Shukla Applications of Emerging Nanomaterials and Nanotechnology 148, 252-275, 2023 | | 2023 |
| Fungal Resistance to Antibiotics Y Mishra, S Bose, P Nayak, N Giri, CM Hussain Antimicrobial Resistance: Opportunities and Challenges 1, 81-104, 2020 | | 2020 |
| Viral Drug Resistance N Giri, V Mishra Antimicrobial Resistance: Opportunitities and Challenges 1, 191-214, 2020 | | 2020 |
| Development of Advanced Delivery Systems for Microbicides N Giri University of Missouri-Kansas City, 2016 | | 2016 |
